cell expression is more frequent in SSc (72.7%) and overlap patients (85.7%) in comparison with SjS (58.2% and P=0.004). Additionally, most of the acinar TGF-β1 staining was strong positive in SSC patients (45.5% vs 19.0% and 3.6%).
Background: Systemic Lupus Erythematosus (SLE) often poses challenges to diagnosis in clinical practice and classification in research. The 2012 SLICC criteria have been recently introduced, with validation studies suggesting greater sensitivity yet equal or lower specificity compared to the 1997 ACR criteria. However, the prognostic significance of classifying SLE patients with the SLICC 2012 versus the ACR 1997 criteria is not known. Objectives: To evaluate the impact of SLICC 2012 versus ACR 1997 SLE classification in terms of clinical characteristics and outcome. Methods: Both the SLICC 2012 and the ACR 1997 classification criteria were applied to adult SLE patients enrolled in the community-based Cretan Lupus Registry over the period 1999-2013. Classified cases were assessed at the end of 2013 in terms of disease severity (determined by the severity of manifestations and the use of lupus treatments) and organ damage (assessed by the SLICC/ACR damage index). Cases who fulfilled both criteria during the observation period were categorized according to which set of criteria was satisfied first and then compared for the frequency of individual criteria. Results: At the end of the observation period (year 2013), fewer SLE patients had been classified with the SLICC 2012 (n=602) as compared with the ACR 1997 (n=750) criteria. The female-to-male ratio (12.6:1 versus 13:1) and the mean (±SD) age at the time of diagnosis (42±15 versus 43±15 years) Background: Moderate-to-severe tubulointerstitial damage (TID) is associated with poor renal outcomes in lupus nephritis (LN) independent of glomerular pathology 1 . Specific antibody profiles associated with TID in LN have not been identified. Unlike glomerular damage, TID is not associated with anti-dsDNA or complement levels
1 . An association between TID and the presence of anti-Ro/La antibodies has been proposed in Sjögren's syndrome 2 . Whether these antibodies are associated with TID in LN is not known. Objectives: To study an association between anti-Ro/La antibodies and moderateto-severe TID in LN. Methods: We identified all patients who fulfilled ACR and/or SLICC criteria for SLE. Patients were included if they had an index renal biopsy consistent with LN between January 2005 and July 2015 and had complete data on TID and anti-Ro/La. Medical history, demographic and laboratory data were ascertained from chart review. TID was defined as the presence of moderate or severe tubular atrophy and/or interstitial fibrosis from the renal biopsy reports. Results: of the 157 LN patients, 39 (25%) had moderate/severe TID (Table) . As expected, moderate/severe TID was associated with older age, class III/IV±V LN and lower estimated glomerular filtration rate (eGFR) at biopsy. Anti-Ro antibodies were present in 55 (47%) of patients with none/mild TID and 17 (44%) of patients with moderate/severe TID (p=0.74). Both anti-Ro and anti-La antibodies were present in 11 (9%) of patients with none/mild TID vs 11 (28%) of patients with moderate/severe TID (p=0.003). In the logistic regression model adjusted for age, eGFR and LN class, the presence of both anti-Ro and anti-La antibodies was associated with a 3-fold increase in the odds of TID, OR 3.1, 95% CI (1.1-9.1), p=0.04. 
